<DOC>
	<DOCNO>NCT01180283</DOCNO>
	<brief_summary>Sixty diabetes men erectile dysfunction mild severe agree participate go medical care approximately 16 week . During first 4 week , patient receive inhibitor phosphodiesterase 5 . In follow eight week , patient receive oral lodenafil carbonate . They complete International Index Erectile Dysfunction ( IIEF ) questionnaire site answer Sexual Encounter Profile ( SEP ) question 2 3 Erection Hadness Score ( EHS ) intercourse attempt without use oral lodenafil cardonate 80mg . Questionnaire adverse event include patient diary .</brief_summary>
	<brief_title>Efficacy Safety Lodenafil Carbonate Treatment Erectile Dysfunction Patients With Diabetes .</brief_title>
	<detailed_description>This prospective , fix dose , open label study . The run period inclusion conclusion fourteen sixteen week . Visit zero ( Vo ) : - Patients sign inform consent form ; - Investigator clinically evaluate subject regard eligibility criterion ; - Safety laboratory test perform ; - Patients answer erectile function domain International Index Erectile Function ( IIEF ) ; Study coordinator : Will orientate subject regard follow : - Patients use phosphodiesterase- 5 inhibitor ( iPDE-5 ) four week ; - When intercourse attempt happen , subject fill diary ; Patients ' diary include : question 2 3 Sexual Encounter Profile ( SEP ) , Erectile Hardness Score ( EHS ) adverse event data . Subject return four week . Visit One ( V1 ) : - Patients answer basal IIEF ; - Investigator inform patient laboratory test result ; Study coordinator : - Will give patient eight pill lodenafil carbonate ; - Will give instruction study medication ; Patient take one pill six two hour intercourse attempt , without food intake drink . The patient take one pill daily . - When intercourse attempt happen , subject fill diary ; Patients ' diary include : question 2 3 Sexual Encounter Profile ( SEP ) , Erectile Hardness Score ( EHS ) adverse event data . Subject return four week . Visit two ( V2 ) Study coordinator : - Will give patient eight pill lodenafil carbonate ; - Will give instruction study medication : Patient take one pill six two hour intercourse attempt , without food intake drink . The patient take one pill daily . - When intercourse attempt happen , subject fill diary ; Patients ' diary include : question 2 3 Sexual Encounter Profile ( SEP ) , Erectile Hardness Score ( EHS ) adverse event data . Subject return four week . Visit three ( V3 ) - Patients answer International Index Erectile Function ( IIEF ) ; - Safety laboratory perform ; Visit four ( V4 ) - Investigator inform patient laboratory test result ; Complete medical evaluation include adverse event question physical examination do visit . Efficacy assess file patient complete study protocol violation ( per protocol population ) . Main outcomes measure efficacy : IIEF ( question 1 15 ) , SEP question 2 ( Were able insert penis partner 's vagina ? ) , SEP question 3 ( Did erection last long enough successful intercourse ? ) , EHS ( Erection Hardness Score ) . Tolerability assess file patient intend treat - subject take study medication least . Patients logs contain question : Did experience uncomfortable symptom ? ; At time symptom begin ? ; Did take medication relieve symptom ? ; Did go hospital /or doctor 's office ? . After review log , investigator interview patient fill adverse event report . Investigator assess event intensity ( mild severe ) define casual relationship study medication ( definite ; probable ; possible ; doubtful ) .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<criteria>Diabetes type II ; Age 18 65 year ; Erectile dysfunction within previous 6 month ; Mild , moderate severe erectile dysfunction IIEF questionnaire ; Stable sexual partner past 2 month ; Preserved libido ; Studied least fourth grade ; Current beta blocker , thiazide , alpha methyldopa , antidepressant , antiandrogen therapy intake ; Penile prosthesis ; Previous intolerance sildenafil , vardenafil , tadalafil lodenafil carbonate ; Previous negative response iPDE5 correct use . ; Penile anatomical deformity ; Previous penile surgery erectile dysfunction , premature ejaculation penile enlargement ; Myocardial infarction cerebral vascular accident within previous 6 month ; Severe uncontrolled cardiac disease ; Spinal cord injury , multiple sclerosis , retinitis pigmentosa ; Radical pelvic surgery pelvic radiotherapy , include radical prostatectomy ; Myocardial Coronary Artery disease cardiologist contraindication use iPDE5 ; Cancer ; Anaphylactic reaction StevenJohnson disease ; Participation another clinical trial within last 2 month ; Sexually transmit disease ; Glycated hemoglobin &gt; 12 % ; Testosterone &lt; 200ng/dL ; Prolactin &gt; 20ng/dL ; Hemoglobin &lt; 10g/dL ; Leucocytes &gt; 14.000 cel/mm3 ; TGO &gt; 100 U/L ; TGP &gt; 100 U/L ; Creatina &gt; 2 mg/dL ; InvestigatorÂ´s opinion ;</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Erectile dysfunction</keyword>
	<keyword>Lodenafil carbonate</keyword>
	<keyword>Diabetes</keyword>
</DOC>